Right-to-try bill headed for vote puts bigger burden on FDA to protect patients, Gottlieb says
The House is set to take up a controversial “right-to-try” bill next week — and if it passes, the FDA will have to work harder to protect patients than it…
WHITE OAK, Md. — The House is set to take up a controversial “right-to-try” bill next week — and if it passes, the Food and Drug Administration will have to work harder to protect patients than it would if a different version of the legislation were advancing, Commissioner Scott Gottlieb told STAT in an interview.
Gottlieb’s comments, made at FDA headquarters on Thursday, indicate that one of President Trump’s top lieutenants believes Congress is but ultimately stalled in the Senate.
